prikaz prve stranice dokumenta Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity
  Preuzmi
PDF 2.35 MB
Znanstveni rad - Pregledni rad
Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity
International Journal of Molecular Sciences, 25 (2024), 3; 1517. https://doi.org/10.3390/ijms25031517
Eržen, Stjepan; Tonin, Gašper; Jurišić Eržen, Dubravka; Klen, Jasna

Citirajte ovaj rad

Eržen, S., Tonin, G., Jurišić Eržen, D. i Klen, J. (2024). Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. International Journal of Molecular Sciences, 25. (3). doi: 10.3390/ijms25031517

Eržen, Stjepan, et al. "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity." International Journal of Molecular Sciences, vol. 25, br. 3, 2024. https://doi.org/10.3390/ijms25031517

Eržen, Stjepan, Gašper Tonin, Dubravka Jurišić Eržen i Jasna Klen. "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity." International Journal of Molecular Sciences 25, br. 3 (2024). https://doi.org/10.3390/ijms25031517

Eržen, S., et al. (2024) 'Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity', International Journal of Molecular Sciences, 25(3). doi: 10.3390/ijms25031517

Eržen S, Tonin G, Jurišić Eržen D, Klen J. Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. International Journal of Molecular Sciences [Internet]. 26.01.2024. [pristupljeno 07.05.2024.];25(3). doi: 10.3390/ijms25031517

S. Eržen, G. Tonin, D. Jurišić Eržen i J. Klen, "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity", International Journal of Molecular Sciences, vol. 25, br. 3, Siječanj 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:095919. [Citirano: 07.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:095919
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity
AutorStjepan Eržen
AutorGašper Tonin
AutorDubravka Jurišić Eržen
AutorJasna Klen
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Diabetes mellitus is a devastating chronic metabolic disease. Since the majority of type 2 diabetes mellitus patients are overweight or obese, a novel term—diabesity—has emerged. The gut–brain axis plays a critical function in maintaining glucose and energy homeostasis and involves a variety of peptides. Amylin is a neuroendocrine anorexigenic polypeptide hormone, which is co-secreted with insulin from β-cells of the pancreas in response to food consumption. Aside from its effect on glucose homeostasis, amylin inhibits homeostatic and hedonic feeding, induces satiety, and decreases body weight. In this narrative review, we summarized the current evidence and ongoing studies on the mechanism of action, clinical pharmacology, and applications of amylin and its analogs, pramlintide and cagrilintide, in the field of diabetology, endocrinology, and metabolism disorders, such as obesity.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaInternational Journal of Molecular Sciences
Brojčani podacivol. 25, br. 3, 1517
e-ISSN1422-0067
DOIhttps://doi.org/10.3390/ijms25031517
URN:NBNurn:nbn:hr:184:095919
Datum objave publikacije2024-01-26
URL dokumentahttps://www.mdpi.com/1422-0067/25/3/1517
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2024-02-20 10:46:32